iRhythm Holdings, Inc. IRTC

Company Overview

iRhythm Technologies, Inc. is a U.S.-based digital healthcare company focused on cardiac monitoring and arrhythmia diagnostics. The company operates primarily in the ambulatory cardiac monitoring market, combining wearable biosensor technology, cloud-based data analytics, and clinical reporting services to assist healthcare providers in diagnosing cardiac arrhythmias. iRhythm’s business is centered on improving the detection of conditions such as atrial fibrillation and other irregular heart rhythms through continuous long-term monitoring solutions used in outpatient settings.

The company’s principal revenue driver is the Zio platform, which includes wearable monitoring patches, data analysis services, and physician reporting capabilities. iRhythm serves hospitals, health systems, cardiology practices, electrophysiologists, and other healthcare providers, primarily in the United States while expanding internationally. The company was founded in 2006 and evolved from an early-stage medical device developer into a digital diagnostics platform company following commercialization of the Zio monitoring system and subsequent scaling of reimbursement coverage and clinical adoption.